|
ZNF235 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.803100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.802940E-03 |
| Normal-vs-Stage2 |
3.522100E-03 |
| Normal-vs-Stage3 |
2.735700E-03 |
| Normal-vs-Stage4 |
5.760800E-03 |
| Stage1-vs-Stage2 |
4.339200E-01 |
| Stage1-vs-Stage3 |
1.587230E-01 |
| Stage1-vs-Stage4 |
4.296600E-01 |
| Stage2-vs-Stage3 |
6.997800E-01 |
| Stage2-vs-Stage4 |
8.422200E-01 |
| Stage3-vs-Stage4 |
8.952600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.802400E-04 |
| Normal-vs-AfricanAmerican |
3.528500E-02 |
| Normal-vs-Asian |
2.785400E-01 |
| Caucasian-vs-AfricanAmerican |
3.816200E-01 |
| Caucasian-vs-Asian |
6.687200E-01 |
| AfricanAmerican-vs-Asian |
8.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.70029999999999E-05 |
| Normal-vs-Female |
2.894600E-01 |
| Male-vs-Female |
9.418600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.166220E-01 |
| Normal-vs-Extreme_Weight |
5.58969999999714E-05 |
| Normal-vs-Obese |
1.858090E-02 |
| Normal-vs-Extreme_Obese |
2.068400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.570200E-02 |
| Normal_Weight-vs-Obese |
6.710200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.264800E-01 |
| Extreme_Weight-vs-Obese |
1.312160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.031400E-01 |
| Obese-vs-Extreme_Obese |
5.309000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.254400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.241590E-01 |
| Normal-vs-Age(61-80Yrs) |
4.26379999995952E-06 |
| Normal-vs-Age(81-100Yrs) |
5.982900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.142000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.862100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.547700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.591200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.842100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.107200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.355950E-02 |
| Normal-VS-Type2 PRCC |
1.0370999999898E-06 |
| Normal-VS-KIRP CIMP |
3.740200E-02 |
| Normal-VS-Unclassified PRCC |
6.366000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.192520E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.676600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.607400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.321600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.786080E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.382200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8107000000489E-06 |
| Normal-vs-N1 |
3.102300E-02 |
| Normal-vs-N2 |
3.575200E-03 |
| N0-vs-N1 |
2.935000E-01 |
| N0-vs-N2 |
3.981800E-01 |
| N1-vs-N2 |
3.004200E-01 |
|
|
